Facebook
Twitter
Telegram
Report an ErrorMatinas BioPharma Holdings Financial Ratios 2011-2024 | MTNB
Annual Financial Ratios Matinas BioPharma Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.5 | -4.6 | -9.1 | -12.9 | -11.5 | -6.8 | -6.7 | -16.5 | -3.4 | -1.6 | - | - | - |
P/S |
73.3 | 30.6 | 6432.7 | 1834.2 | 2231.0 | 802.8 | 695.1 | - | 158.8 | - | - | - | - |
EPS |
-0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.4 | -0.2 | -0.2 | -0.3 | -0.2 | - | - |
EV (Enterprise Value) |
81.5 M | 98.9 M | 200 M | 285 M | 185 M | 87.5 M | 100 M | 124 M | 30 M | 14.6 M | -9.98 M | - | - |
EBITDA per Share |
-0.11 | -0.11 | -0.12 | -0.118 | -0.125 | -0.147 | -0.181 | -0.142 | -0.192 | -0.325 | - | - | - |
EV/EBITDA |
-8.1 | -11.9 | -9.8 | -5.8 | -5.9 | -14.8 | -2.8 | -1.3 | - | - | - | ||
PEG |
0.64 | 0.5 | 4.39 | -1.68 | -0.87 | -0.12 | 0.09 | 0.99 | -0.08 | 0.01 | - | - | - |
P/B |
4.2 | 2.7 | 4.0 | 4.6 | 6.1 | 6.0 | 9.7 | 17.6 | 5.1 | 7.2 | - | - | - |
P/CF |
-5.3 | -5.1 | -13.9 | -16.7 | -13.8 | -8.9 | -8.4 | -20.5 | -3.9 | -1.9 | - | - | - |
ROE % |
-119.20 | -57.31 | -44.35 | -35.22 | -52.56 | -87.25 | -144.98 | -106.28 | -150.44 | -458.78 | - | - | - |
ROA % |
-91.39 | -46.85 | -37.97 | -31.63 | -43.17 | -70.62 | -107.37 | -77.41 | -108.68 | -304.07 | - | - | - |
ROCE % |
-105.71 | -60.67 | -43.41 | -35.91 | -50.94 | -85.64 | -135.28 | -98.63 | -136.19 | -466.52 | - | - | - |
Current Ratio |
4.3 | 5.5 | 6.9 | 17.3 | 9.7 | 4.6 | 3.6 | 3.2 | 3.2 | 2.5 | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Matinas BioPharma Holdings
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.03 | -0.03 | -0.03 | - | -0.03 | -0.03 | -0.03 | - | -0.03 | -0.02 | -0.03 | - | -0.03 | -0.03 | -0.03 | - | -0.03 | -0.03 | -0.04 | - | -0.03 | -0.04 | -0.05 | - | -0.04 | -0.04 | -0.25 | - | -0.11 | -0.03 | -0.04 | - | -0.04 | -0.04 | -0.07 | - | -0.08 | -0.08 | -0.07 | - | -0.1 | -0.03 | -0.01 | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.03 | -0.03 | -0.03 | - | -0.02 | -0.03 | -0.04 | - | -0.03 | -0.02 | -0.03 | - | -0.03 | -0.03 | -0.03 | - | -0.03 | -0.03 | -0.03 | - | -0.03 | -0.04 | -0.04 | - | -0.04 | -0.04 | -0.05 | - | -0.03 | -0.03 | -0.04 | - | -0.04 | -0.04 | -0.07 | - | -0.08 | -0.08 | -0.07 | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-78.95 | -66.94 | -59.01 | -40.50 | -52.24 | -49.83 | -43.63 | -26.80 | -35.35 | -32.17 | -33.35 | -25.27 | -38.60 | -43.37 | -44.69 | -35.70 | -53.89 | -58.75 | -69.76 | -64.78 | -96.56 | -110.15 | -126.17 | -111.01 | -136.73 | -130.66 | -116.23 | -79.82 | 37.10 | 179.74 | 352.31 | 116.92 | 574.75 | 915.66 | 1223.63 | 456.89 | 442.98 | -28.75 | -489.86 | -18.25 | -18.25 | -4.35 | -1.07 | - | - | - | - | - | - | - | - |
ROA % |
-64.03 | -55.19 | -48.68 | -33.50 | -43.71 | -42.43 | -37.98 | -23.90 | -31.58 | -29.06 | -30.11 | -22.69 | -33.64 | -36.91 | -37.31 | -29.32 | -44.04 | -47.82 | -56.61 | -52.43 | -75.97 | -84.78 | -95.19 | -82.22 | -100.94 | -96.14 | -85.17 | -58.14 | 26.33 | 129.52 | 254.31 | 84.46 | 387.90 | 606.88 | 802.07 | 302.81 | 289.96 | -26.33 | -332.79 | -16.87 | -16.87 | -4.02 | -0.99 | - | - | - | - | - | - | - | - |
ROCE % |
-70.85 | -60.57 | -53.57 | -40.25 | -51.19 | -49.32 | -43.94 | -27.21 | -35.53 | -32.91 | -34.25 | -26.29 | -38.57 | -42.53 | -46.15 | -35.50 | -52.77 | -57.76 | -65.50 | -61.27 | -93.18 | -107.82 | -125.13 | -111.14 | -136.80 | -130.56 | -116.00 | -79.62 | -115.17 | -125.06 | -141.95 | -117.40 | -234.34 | -315.74 | -384.83 | -321.15 | -321.15 | -204.21 | -95.56 | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
4.5 | 5.5 | 6.8 | 5.5 | 5.3 | 5.5 | 6.9 | 6.9 | 7.7 | 9.9 | 12.5 | 9.8 | 9.8 | 9.8 | 9.8 | 5.6 | 5.6 | 5.6 | 5.6 | 5.2 | 5.2 | 5.2 | 5.2 | 3.9 | 3.9 | 3.9 | 3.9 | 3.7 | 3.7 | 3.7 | 3.7 | 3.6 | 3.6 | 3.6 | 3.6 | 3.0 | 3.0 | 3.0 | 3.0 | 13.2 | 13.2 | 13.2 | 13.2 | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 34.2 | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 34.2 | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 34.2 | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency